Compare
Illumina vs Thermo Fisher Scientific (ILMN vs TMO)
The two stocks side by side, as of the latest close. Performance is rebased to 100 at the start of the window.
Over the past year Illumina (ILMN) returned +74.1% and Thermo Fisher Scientific (TMO) +22.4%; so far this year the figures are +62.5% and +19.9%.
Thermo Fisher Scientific is the larger company by market value, about 8.0 times the size of Illumina.
On trailing earnings, ILMN trades at 36.7 times and TMO at 36.6 times.
Revenue grew +5.8% at ILMN and +8.3% at TMO over the last year.
ILMN pays no dividend. TMO yields 0.26%.
Data as of the latest close. Not investment advice.
Relative performance
| ILMN | TMO | |
|---|---|---|
| Price | $213.13 | $694.76 |
| 1-day | +2.47% | +2.63% |
| YTD | +62.50% | +19.90% |
| 1 year | +74.07% | +22.39% |
| 3 years | +105.42% | +57.50% |
| Market cap | $32.2B | $257.4B |
| P/E | 36.7 | 36.6 |
| P/S | 7.10 | 5.44 |
| P/B | 10.25 | 4.70 |
| Revenue growth | +5.80% | +8.30% |
| EPS growth | +30.30% | +9.50% |
| Gross margin % | 67.9 | 25.2 |
| Net margin % | 19.7 | 14.9 |
| ROE % | 28.5 | 12.9 |
| Debt / equity | 0.37 | 0.79 |
| FCF yield % | 3.3 | 3.0 |
| Dividend yield % | — | 0.26 |
| Beta | 1.08 | 0.67 |
| RSI (14) | 35.5 | 54.7 |
| Technical rating |